Hafid Remouche / Karima Chikhi-Remouche / Khedidja Belkharroubi
Librería Samer Atenea
Librería Aciertas (Toledo)
Kálamo Books
Librería Perelló (Valencia)
Librería Elías (Asturias)
Donde los libros
Librería Kolima (Madrid)
Librería Proteo (Málaga)
Genetic screening for breast cancer in at-risk women remains a major ethical issue, given that it rejects controversial images, namely:● a frightening image of cancer;● a positive image of cancer screening.This system, which is aimed at women aged 50 to 74, invites them to take part in a two-part screening examination every two years: a first reading, a bilateral mammogram in two incidences (face and oblique) analyzed by a radiologist, followed by a second reading if the mammogram is negative. However, new genetic screening techniques for at-risk individuals have revolutionized the way in which breast cancer is now treated at a very early, even preventive, stage. For this reason, the concept remains a controversial one, since in these cases we’re not talking about sick people, but healthy people who could potentially become ill in the future. This is why I asked myself the following question: 'What is the ethical viewpoint regarding genetic screening for breast cancer in women at risk, with a view to preventive management?